Richard Eskew compensation by year
Accolade Summary Compensation Table · the one fiscal year held| Component | FY2024 |
|---|---|
| Salary | $350,000 |
| Bonus | $0 |
| Stock awards | $664,030 |
| Option awards | $0 |
| Non-equity incentive | $0 |
| Pension and deferred compensation | $0 |
| All other | $3,500 |
| Total | $1,017,530 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Accolade, Inc. DEF 14A filed June 21, 2024, accession 0001481646-24-000029, and prior-year filings. Open the filing on EDGAR.
Equity holdings
unvested awards at FY2024 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 27,259 | $279,405 | — |
| RSU | 6,220 | $63,755 | — |
| RSU | 5,000 | $51,250 | — |
| Option | 20,000 | — | $6.55 |
| Option | 10,250 | — | $4.20 |
| Option | 20,000 | — | $4.70 |
| Option | 12,000 | — | $9.60 |
| Option | 8,291 | — | $53.38 |
| Option | 34,489 | — | $17.50 |
| Option | 16,666 | — | $6.27 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Accolade, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
37 Form 4 lines since the FY2024 proxy (filed June 21, 2024)current to 2026-09-24 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2025-04-08 | Grant or award derivative | — | 27,259 | — | 27,259 |
| 2025-04-08 | Grant or award derivative | — | 37,500 | — | 37,500 |
| 2025-04-08 | Disposition to the issuer derivative | — | 778 | — | 0 |
| 2025-04-08 | Disposition to the issuer derivative | — | 10,602 | — | 0 |
| 2025-04-08 | Disposition to the issuer derivative | — | 37,500 | — | 0 |
| 2025-04-08 | Disposition to the issuer derivative | — | 27,259 | — | 0 |
| 2025-04-08 | Disposition to the issuer derivative | — | 37,500 | — | 0 |
| 2025-04-08 | Disposition to the issuer | — | 66,191 | $7.03 | 0 |
The 8 most recent of 37 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Change-in-control & termination
estimated payments Accolade discloses, by trigger · FY2024| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Change in control and involuntary termination | — | $695,219 | — | $695,219 |
Per the Potential Payments Upon Termination or Change in Control table in Accolade, Inc.'s FY2024 proxy. Estimates as the company printed them; a dash means it printed no figure.
Accolade’s named executive officers, FY2024
as the company reported each| Named executive officer | Role | FY2024 total |
|---|---|---|
| Rajeev Singh | Chief Executive Officer and Chairman of the Board | $3,823,597 |
| Robert Cavanaugh | President | $1,788,963 |
| Stephen Barnes | Chief Financial Officer | $1,778,963 |
| Richard Eskew · this page | Executive Vice President, General Counsel, and Chief Compliance Officer | $1,017,530 |
The full Accolade compensation record
free company briefThis page is one person within Accolade's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Accolade's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Accolade's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Velarion Pro: every company page, peer tools and exports, one seat